-Charles A Thornton Researcher Activity Profile

Research Author Detailed Information 

Charles A Thornton Publication Rate By Year

Charles A Thornton has published 2 paper(s) in 2006, 14 paper(s) in 2007, 5 paper(s) in 2008, for a total of 21 research publications in total.

Charles A Ca Thornton Author Information

LAST NAME: thornton

FIRST NAME: Charles A

INITIALS: ca

AFFILIATION:

Papers

Charles A Thornton's Publication Record

1. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Year Published: 2007
Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
2. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Year Published: 2007
Neuromuscular Division, Department of Neurology, Box 673, 601 Elmwood Avenue, University of Rochester Medical Center, Rochester, New York 14642, USA. eric_logigian@urmc.rochester.edu
3. RNA-dominant diseases. Year Published: 2006
Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA.
4. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. Year Published: 2006
Department of Physiology and Pharmacology, University of Rochester, Rochester, NY 14642, USA.
5. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Year Published: 2007
Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642-8673, USA.
6. Muscle growth after postdevelopmental myostatin gene knockout. Year Published: 2007
Department of Medicine, University of Rochester, Rochester, NY, USA. stephen_welle@urmc.rochester.edu
7. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci. Year Published: 2007
Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
8. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1). Year Published: 2007
Department of Neurology, University of Rochester Medical Center, Box 673, 601 Elmwood Avenue, Rochester, New York 14642, USA. RichardT_Moxley@urmc.rochester.edu
9. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Year Published: 2007
Department of Molecular Genetics and Microbiology and the Genetics Institute, University of Florida, College of Medicine, Gainesville, FL, USA.
10. Myotonic dystrophy: RNA-mediated muscle disease. Year Published: 2007
Department of Neurology, University of Rochester, Rochester, New York, USA.
11. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. Year Published: 2007
Department of Neurology and Department of Pharmacology and Physiology, University of Rochester, Rochester, New York, USA. Department of Molecular Genetics and Microbiology, Genetics Institute, University of Florida, Gainesville, Florida, USA.
12. RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Year Published: 2007
Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, USA.
13. The hypocretin neurotransmission system in myotonic dystrophy type 1. Year Published: 2008
University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA. Emma_Ciafaloni@urmc.rochester.edu
14. Sex-related differences in gene expression in human skeletal muscle. Year Published: 2008
Department of Medicine, University of Rochester, Rochester, New York, United States of America.
15. RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Year Published: 2007
Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, USA.
16. The hypocretin neurotransmission system in myotonic dystrophy type 1. Year Published: 2008
University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642 Emma_Ciafaloni@urmc.rochester.edu.
17. The hypocretin neurotransmission system in myotonic dystrophy type 1. Year Published: 2008
University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA. Emma_Ciafaloni@urmc.rochester.edu
18. RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Year Published: 2007
Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, USA.
19. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. Year Published: 2007
Department of Neurology, University of Rochester, Rochester, New York 14618, USA.
20. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. Year Published: 2007
Department of Neurology, University of Rochester, Rochester, New York 14618, USA.
21. The hypocretin neurotransmission system in myotonic dystrophy type 1. Year Published: 2008
University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA. Emma_Ciafaloni@urmc.rochester.edu